Study of JYB1904 for chronic spontaneous urticaria
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with chronic spontaneous urticaria (hives with no clear cause) for at least 6 months.
- You have had itching and hives for at least 6 weeks in a row at some point before screening.
- You are currently taking a stable dose of a second-generation antihistamine (like cetirizine or loratadine) for at least 6 weeks.
- Your hives are not triggered by things like pressure, cold, heat, water, or exercise.
- You do not have other skin conditions that cause itching (like eczema or psoriasis) or a history of severe allergic shock.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, JYB1904, for people with chronic hives (itching and welts) that haven't been controlled by standard allergy pills. It aims to see if JYB1904 can reduce itching and hives better.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests a new medication (HS-10561) first in healthy adults to check safety, then in people with chronic spontaneous urticaria (long-term hives without a known cause) to see if it helps reduce symptoms. It may be an option for those who have had hives for at least 6 months.
This trial tests a new medication (HRS-3095) for chronic spontaneous urticaria—persistent hives that don't go away despite taking standard antihistamine pills. If your hives have lasted months and remain poorly controlled, this study may help you find relief.
This trial tests an experimental drug called HRS-3095 in healthy people to check its safety and how the body handles it. It may help find the right dose for future studies.
This trial tests a new injection (CM512) for people with chronic spontaneous urticaria, also known as chronic hives. If you have had itchy hives for at least 6 weeks despite taking regular antihistamines, this study may help find a new treatment option.
Hear when a new Chronic Spontaneous Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.